Clinical Trial Update: Lung Diffusing Capacity for Nitric Oxide as a Marker of Fibrotic Changes in Idiopathic Interstitial Pneumonias

View source ↗

Summary

A completed clinical trial investigated using lung diffusing capacity for nitric oxide as a biomarker for fibrotic changes in idiopathic interstitial pneumonias…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonspecific Interstitial Pneumonia
• Usual Interstitial Pneumonia

Snippet

Sponsor: IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | Conditions: Usual Interstitial Pneumonia, Nonspecific Interstitial Pneumonia | Status: COMPLETED